Harvard Apparatus Regenerative Technology Inc

For the period ended Jun 30, 2024. Filed Aug 13, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 13, 2024

HRGNStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

(in thousands, except share data)

Series E Convertible Preferred · Number of Common Shares · Common · Additional Paid-in · Accumulated · Accumulated Other Comprehensive · Total Stockholders’ Equity
Stock · Outstanding · Stock · Capital · Deficit · Loss · (Deficit)
Balance at April 1, 2024	-	$—	13,947,324	$139	$94,023	$(93,986)	$(1)	$175
Share-based compensation		—	—	—	572	—	—	572
Issuance of common stock		—	367,767	4	1,478	—	—	1,482
Net loss	-	—	—	—	—	(2,498)	—	(2,498)
Other comprehensive loss		—	—	—	—	—	(21)	(21)
Balance at June 30, 2024	-	$—	14,315,091	$143	$96,073	$(96,484)	$(22)	$(290)

	Series E Convertible Preferred	Number of Common Shares	Common	Additional Paid-in	Accumulated	Total Stockholders’ (Deficit)
	Stock	Outstanding	Stock	Capital	Deficit	Equity
Balance at April 1, 2023	$4,051	12,716,534	$127	$84,712	$(85,901)	$(1,062)
Preferred stock dividends	(3)	—	—	3	—	3
Conversion of preferred stock for common stock	(4,048)	674,693	7	4,041	—	4,048
Issuance of common stock, net of offering costs	—	490,833	5	2,937	—	2,942
Share-based compensation expense	—	—	—	479	—	479
Net loss	—	—	—	—	(2,614)	(2,614)
Balance at June 30, 2023	$—	13,882,060	$139	$92,172	$(88,515)	$3,796

	Series E Convertible Preferred	Number of Common Shares	Common	Additional Paid-in	Accumulated	Accumulated Other Comprehensive	Total Stockholders’ Equity
	Stock	Outstanding	Stock	Capital	Deficit	Loss	(Deficit)
Balance at January 1, 2024	$—	13,947,324	$139	$93,463	$(91,956)	$—	$1,646
Share-based compensation	—	—	—	1,132	—	—	1,132
Issuance of common stock	—	367,767	4	1,478	—	—	1,482
Net loss	—	—	—	—	(4,528)	—	(4,528)
Other comprehensive loss	—	—	—	—	—	(22)	(22)
Balance at June 30, 2024	$—	14,315,091	$143	$96,073	$(96,484)	$(22)	$(290)

	Series E Convertible Preferred	Number of Common Shares	Common	Additional Paid-in	Accumulated	Total Stockholders’ (Deficit)
	Stock	Outstanding	Stock	Capital	Deficit	Equity
Balance at January 1, 2023	$4,180	12,174,467	$122	$79,698	$(83,011)	$(3,191)
Preferred stock dividends	77	—	—	(77)	—	(77)
Conversion of preferred stock for common stock	(4,257)	706,626	7	4,250	—	4,257
Issuance of common stock, net of offering costs	—	1,000,967	10	5,982	—	5,992
Share-based compensation expense	—	—	—	2,319	—	2,319
Net loss	—	—	—	—	(5,504)	(5,504)
Balance at June 30, 2023	$—	13,882,060	$139	$92,172	$(88,515)	$3,796

See accompanying notes to unaudited condensed consolidated financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.